Integrated Investment Consultants, LLC Genmab A/S Transaction History

Integrated Investment Consultants, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jul 18, 2023	BUY	$34.88 - $43.22 $479,181 - $593,756	13,738 New	13,738 $518,000
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $83,959 - $116,897	-2,484 Reduced 13.48%	15,946 $675,000
Q3 2022 Nov 21, 2022	SELL	$31.52 - $373.61 $3,782 - $44,833	-120 Reduced 0.65%	18,430 $592,000
Q2 2022 Jul 19, 2022	SELL	$26.83 - $38.57 $34,074 - $48,983	-1,270 Reduced 6.41%	18,550 $602,000
Q1 2022 May 16, 2022	SELL	$30.95 - $39.68 $82,636 - $105,945	-2,670 Reduced 11.87%	19,820 $717,000
Q4 2021 Jan 10, 2022	SELL	$35.87 - $47.12 $2,654 - $3,486	-74 Reduced 0.33%	22,490 $889,000
Q3 2021 Oct 28, 2021	BUY	$41.55 - $48.72 $17,201 - $20,170	414 Added 1.87%	22,564 $986,000
Q2 2021 Jul 21, 2021	BUY	$32.88 - $44.57 $257,450 - $348,983	7,830 Added 54.68%	22,150 $905,000
Q1 2021 Apr 20, 2021	SELL	$30.92 - $44.4 $95,233 - $136,752	-3,080 Reduced 17.7%	14,320 $471,000
Q4 2020 Feb 09, 2021	BUY	$33.66 - $40.76 $50,489 - $61,140	1,500 Added 9.43%	17,400 $708,000
Q3 2020 Oct 26, 2020	BUY	$33.07 - $38.68 $279,441 - $326,846	8,450 Added 113.42%	15,900 $583,000
Q2 2020 Aug 04, 2020	BUY	$20.05 - $33.89 $149,372 - $252,480	7,450 New	7,450 $252,000

240

52.6M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Investment Consultants, LLC with notifications on news.